Skip to content

Cognitive behavioral therapy combined with medication in adults with attention-deficit/hyperactivity disorder: a randomized controlled trial

Cognitive behavioral therapy combined with medication in adults with attention-deficit/hyperactivity disorder: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044201
Enrollment
Unknown
Registered
2021-03-12
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention-deficit/hyperactivity disorder

Interventions

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Outpatients attending the Sixth Hospital of Peking University with age 18-45 years old and willing to attend CBT therapy; 2. Outpatients from Peking University Sixth Hospital, having received a diagnosis of adult ADHD through Conners Adult ADHD Diagnostic Interview based on Diagnostic and Statistical Manual of mental disorders, Fifth Edition and with CGI score >= 3; 3. Patients who were either drug-naive or have been stable on medications (for the treatment of ADHD, drug dosage adjustment in the last two months was below 10% for at least 2 months). 4. No other severe comorbidities (see exclusion criteria), or stable mild or moderate depressive episodes, dysthymia, bipolar disorder, anxiety disorder, eating disorder; No other medications or stable use of antidepressants, mood stabilizers, benzodiazepines (dose fluctuation < 10% within 2 months).

Exclusion criteria

Exclusion criteria: 1. Patients with current mental disorders: major depressive episodes with psychotic symptoms or high suicide/self-injury risk, severe panic disorder, psychotic disorders, bipolar disorder, substance dependence, generalized developmental disorders, anti-Social personality disorder; 2. Those whose intelligence level is lower than the normal range; 3. Those who have a clear concept of suicide; 4. According to the researcher's judgment, the patient's physical condition is unstable or inadequately treated (such as diabetes, angina pectoris, hypertension, active hepatitis, etc.); 5. Those who have participated in other psychotherapists.

Design outcomes

Primary

MeasureTime frame
ADHD Rating Scale;BIS-Barratt Impulse Scale;

Secondary

MeasureTime frame
Zung Self-rating Depression Scale;Zung Self-rating Anxiety Scale;Emotion Regulation Questionnaire;Difficulties in Emotion Regulation Scale;Automatic Thoughts Questionnaire;Sheehan Disability Scale;the Brief Version of the World Health Organization Quality of Life Scale;Behavior Rating Inventory of Executive Function - Adult Version;

Countries

China

Contacts

Public ContactQian Qiujin

Peking University Sixth Hospital

qianqiujin@bjmu.edu.cn+86 10 6272 3701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 11, 2026